insights_auto
Why is DGX up 3.54%?
Dive Deeperchevron_right
DGX:NYSE
Quest Diagnostics Inc
$255.68
arrow_upward
+3.54%(+8.74) 1D
$255.68
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 4, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DGX...
Open
$250.61
High
$255.81
Low
$247.39
Mkt. cap
28.13B
Avg. vol.
1.05M
Volume
915.86K
Dividend
1.35%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
25.50
52-wk high
$256.99
52-wk low
$171.18
EPS
$10.03
Beta
0.55
Shares outstanding
110.02M
No. of employees
52K
Open
$250.61
High
$255.81
Low
$247.39
Mkt. cap
28.13B
Avg. vol.
1.05M
Volume
915.86K
Dividend
1.35%
Quarterly dividend
$0.86
Ex-dividend date
Oct 6, 2026
P/E ratio
25.50
52-wk high
$256.99
52-wk low
$171.18
EPS
$10.03
Beta
0.55
Shares outstanding
110.02M
No. of employees
52K
News stories
From web sources and news partners
News Corp
·
1 hour ago
Quest Diagnostics Inc. stock outperforms competitors on strong trading day
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees51.5K
Founded1967
Headquarters-
SectorHealth care provider
Industry-
Websitequestdiagnostics.com